AO Research Institute Davos, Davos, Switzerland.
Department of Orthopaedic Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Arthritis Res Ther. 2022 May 11;24(1):105. doi: 10.1186/s13075-022-02785-y.
Osteoarthritis (OA) is one of the most common musculoskeletal degenerative diseases and contributes to heavy socioeconomic burden. Current pharmacological and conventional non-pharmacological therapies aim at relieving the symptoms like pain and disability rather than modifying the underlying disease. Surgical treatment and ultimately joint replacement arthroplasty are indicated in advanced stages of OA. Since the underlying mechanisms of OA onset and progression have not been fully elucidated yet, the development of novel therapeutics to prevent, halt, or reverse the disease is laborious. Recently, small molecules of herbal origin have been reported to show potent anti-inflammatory, anti-catabolic, and anabolic effects, implying their potential for treatment of OA. Herein, the molecular mechanisms of these small molecules, their effect on physiological or pathological signaling pathways, the advancement of the extraction methods, and their potential clinical translation based on in vitro and in vivo evidence are comprehensively reviewed.
骨关节炎(OA)是最常见的肌肉骨骼退行性疾病之一,给社会经济带来了沉重负担。目前的药物和传统非药物疗法旨在缓解疼痛和残疾等症状,而不是改变潜在疾病。在 OA 的晚期,需要进行手术治疗,最终进行关节置换术。由于 OA 发病和进展的潜在机制尚未完全阐明,因此开发预防、阻止或逆转疾病的新型疗法非常困难。最近,有报道称源自草药的小分子具有很强的抗炎、抗分解和合成代谢作用,这表明它们具有治疗 OA 的潜力。本文综合综述了这些小分子的分子机制、对生理或病理信号通路的影响、提取方法的进展,以及基于体外和体内证据的潜在临床转化。